Amwill Health Care Limited is a derma-cosmetic product developer specializing in dermatological, cosmeceutical, and aesthetic solutions. By outsourcing manufacturing, prototype development, and distribution to trusted third-party partners, it focuses entirely on product formulation and innovation. Its operations are divided into two key areas: (i) contract development and manufacturing of generic dermatology products, and (ii) formulation of targeted solutions for specific skin concerns
Price Band₹105 - ₹111 |
Dates05 Mar - 07 Feb |
GMP₹0 (0.00%) |
Subscriptions- |
Issue Size₹59.98 Crs |
Price Band₹105 - ₹111 |
Listing AtBSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹48.88 Cr (0.44 Cr Shares) |
Offer For Sale₹11.10 Cr (0.10 Cr Shares) |
Total Issue₹59.98 Cr (0.54 Cr Shares) |
Face Value₹10 per equity share |
Investor Category | Lot | Shares | Amount | |
---|---|---|---|---|
Retail |
Minimum
1
1,200
1,33,200
Maximum
1
1,200
1,33,200
|
|||
NII |
Minimum
2
2,400
2,66,400
|
The estimated Grey Market Premium of Amwill Health Care IPO is ₹0 per share (0.00%)
Particulars | Allocation |
---|---|
QIB | Not more than 20% of Net Offer |
NII | Not less than 40% of Net Offer |
Retail | Not less than 40% of Net Offer |
Market Maker | 2,71,200 EQ Share |
Particulars | Sep-24 | Mar-24 | Mar-23 | Mar-22 |
---|---|---|---|---|
Revenue from Operations | 23.16 | 43.95 | 30.17 | 27.61 |
Profit after Tax | 6.52 | 12.54 | 3.11 | 2.57 |
Net Worth | 23.68 | 17.16 | 4.60 | 1.49 |
Total Borrowing | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 28.89 | 18.98 | 12.39 | 6.59 |
NAV per share (in ₹) | 15.18 | 11.00 | 2.95 | 0.95 |
EPS - Basic (in ₹) | 4.18 | 8.04 | 2.00 | 1.65 |
The financial information presented is on a consolidated basis.
KPI | KPI |
---|---|
EBITDA | 37.92% |
PAT | 28.53% |
ROE | 73.06% |
ROCE | 94.16% |
PE Ratio | 13.81 |
PB Ratio | 10.09 |
Mkt Cap (in Crs.) | 222.04 |
Particulars | Co. | Vaishali Pharma | Trident Lifeline |
---|---|---|---|
Revenue from Ops (in Crs.) | 43.95 | 86.28 | 44.65 |
PAT (In Crs.) | 12.54 | 0.72 | 7.04 |
EPS - Basic | 8.04 | 0.68 | 6.13 |
NAV per share | 11.00 | 39.97 | 45.81 |
RONW | 73.06% | 1.68% | 13.37% |
EBITDA | 37.92% | 1.32% | 19.77% |
PAT Margin | 28.53% | 0.83% | 15.77% |
Price to earning (PE) | 13.81 | 26.45 | 45.06 |
Particulars | Co. |
---|---|
Revenue from Ops (in Crs.) | 43.95 |
PAT (In Crs.) | 12.54 |
EPS - Basic | 8.04 |
NAV per share | 11.00 |
RONW | 73.06% |
EBITDA | 37.92% |
PAT Margin | 28.53% |
Price to earning (PE) | 13.81 |
Vaishali Pharma | Trident Lifeline |
---|---|
86.28 | 44.65 |
0.72 | 7.04 |
0.68 | 6.13 |
39.97 | 45.81 |
1.68% | 13.37% |
1.32% | 19.77% |
0.83% | 15.77% |
26.45 | 45.06 |
Name | Shareholding |
---|---|
Anand Gandhi | 40.57% |
Tarun Gandhi | 40.57% |
Other Promoter | 15.86% |
Name | Designation |
---|---|
Tarun Gandhi | Chairman & MD |
Anand Gandh | MD |
Sharanya Nagaraj | CFO |
Name : Amwill Health Care Limited
Address : No. 90, 4th Floor, 2nd Main, 7th Cross, Chamrajpet, Bangalore – 560 018, Karnataka, India
Number : +91 802 660 5825
Email : amwill@amwillhealthcare.com
Website : www.amwillhealthcare.com
Find answers to common questions that come in your mind related to IPO.
Amwill Health Care IPO is a SME IPO having an issue size of Rs. ₹59.98 Crs. Amwill Health Care IPO is priced at ₹105 - ₹111 per share. The issue opens on 05 Mar 25 and closes on 07 Feb 25.
Amwill Health Care IPO opens on 05 Mar 25 and closes on 07 Feb 25.
The estimated Grey Market Premium of Amwill Health Care IPO is ₹0 per share (0.00%).
The minimum lot size of Amwill Health Care IPO is 1200 shares & the minimum application amount is Rs. 133200.
The allotment date of Amwill Health Care IPO is 10 Feb 25.
The listing date of Amwill Health Care IPO is 12 Feb 25.
Amwill Health Care IPO is subscribed -.
Amwill Health Care IPO is priced at ₹105 - ₹111 per share.
Click the allotment link on Amwill Health Care IPO page of IPO360.